Written by The Sterility Testing Market is benefiting from increasing regulatory attention toward contamination control in sterile manufacturing. Pharmaceutical companies must maintain strict quality systems to ensure that sterile products meet applicable safety and quality requirements. The expansion of advanced therapies and complex biologic products is further increasing the need for specialized laboratory testing. Contract testing organizations are also gaining opportunities as smaller pharmaceutical companies increasingly outsource quality-control activities.
Membrane filtration remains an important testing approach because of its established use across pharmaceutical manufacturing. Direct transfer is another method used for products that cannot be effectively filtered. At the same time, rapid microbiological testing is emerging as a significant area of innovation. Market Analysis indicates that laboratories combining validated methods with automation, digital data management, and efficient workflows can benefit from increasing demand for high-quality sterility assurance services.
FAQ: What is membrane filtration?
It is a testing method in which a sample is passed through a membrane that can be examined for microbial growth.
FAQ: Why is outsourcing increasing?
Outsourcing can allow pharmaceutical companies to access specialized testing capabilities without maintaining all laboratory infrastructure internally.